key: cord-0840151-4swiyxa2
authors: Kiyatkin, Michael E.; Levine, Samantha P.; Kimura, Atsumi; Linzer, Ryan W.; Labins, Jacqueline R.; Kim, Joseph I.; Gurvich, Aryeh; Gong, Michelle N.
title: Increased incidence of post-operative respiratory failure in patients with pre-operative SARS-CoV-2 infection
date: 2021-06-22
journal: J Clin Anesth
DOI: 10.1016/j.jclinane.2021.110409
sha: d84ca32ceef9d2080674464cfcd6a995a4aa442c
doc_id: 840151
cord_uid: 4swiyxa2

Objective While studies have reported increased post-operative pulmonary complications with SARS-CoV-2 infection, many are limited by use of historical controls or focus on less severe respiratory complications. We characterized the association between pre-operative SARS-CoV-2 infection and post-operative respiratory failure (PORF). Design and setting This was a single center retrospective cohort study in New York City between March 14–June 14, 2020. Patients Exclusion criteria were age < 18-years, obstetric procedures, absence of SARS-CoV-2 PCR testing, and pre-operative respiratory failure. A total of 778 patients met criteria, of which 87 had SARS-CoV-2. Measurements The primary outcome, PORF, included inability to extubate for ≥24 h or unplanned re-intubation within 5 days. Multiple exposures were measured including SARS-CoV-2 infection 4 weeks before or 5 days after surgery. Multivariable logistic regression was performed to adjust for pre-operative hypoxemia, oxygen use, and pneumonia as well as tachycardia, gender, Charlson Comorbidity Index (CCI), Surgical Mortality Probability Model (S-MPM) index, and peri-operative blood transfusion. Main results SARS-CoV patients had higher CCI (P = 0.007) and S-MPM scores (P = 0.02). The incidence of PORF was 16% versus 7% in uninfected comparators (P = 0.001). Amongst infected individuals, 39% exhibited symptoms of COVID-19 and PORF was more common in these patients compared to asymptomatic individuals (26% vs. 9%, P = 0.04). Adjusted analysis revealed increased odds of PORF with infection (OR 2.8, 95% CI 1.2–6.2). This persisted even when adjusting for probable mediators such as pre-operative hypoxemia. Infected patients also demonstrated increased adjusted odds of 30-day mortality (OR 3.5, 95% CI 1.4–9.1). Conclusions Detection of SARS-CoV-2 infection within 4 weeks before or 5 days after surgery is associated with increased odds of 5-day PORF and 30-day mortality. This supports delaying elective surgery, but questions remain regarding the applicability of this recommendation for asymptomatic patients needing urgent or semi-urgent procedures such as oncologic surgery.

The Coronavirus disease 2019 pandemic continues to plague the world and its impact on peri-operative care remains a major concern. This is particularly relevant for postsurgical pulmonary complications including post-operative respiratory failure (PORF). PORF is variably defined as severe hypoxemia on room air, ≥24-hour of continued invasive mechanical ventilation (IMV) post-operatively, and/or unplanned reintubation or need for non-invasive ventilation (NIV) within 3-30 days after surgery. Historically, the incidence of these aforementioned adverse events was 0.5-4% after non-cardiac surgery [1, 2] . One major risk factor for PORF is respiratory infection within the previous month, which has been reported to increase the odds of post-operative hypoxemia and other pulmonary complications by nearly 5 times [3, 4] . This may be due to exacerbation of pre-existing infection by surgical immunomodulation and violation of the innate immune barrier during tracheal intubation for general anesthesia [5, 6] . Given the independent 4-17% risk of respiratory failure in COVID-19 [7] [8] [9] , surgery during SARS-CoV-2 infection may constitute a perfect storm for PORF and lead to a high incidence of post-surgical respiratory failure. Moreover, because of the ongoing global [10] and inpatient burden of COVID-19 [11] as well as the importance of reviewing outcomes from resolved outbreaks to prepare for any future surges or similar respiratory pandemics, characterizing in detail SARS-CoV-2 infection-related PORF in both surge and non-surge conditions is an important goal for peri-operative research.

The association between SARS-CoV-2 infection and PORF has been preliminarily explored and there is suggestion of heightened risk. For example, a single-center study from Wuhan, China at the start of the pandemic reported an approximately 30% incidence of re-J o u r n a l P r e -p r o o f Journal Pre-proof intubation of post-operative patients for non-surgical reasons [12] while a subsequent multicenter, primarily British study during surge conditions reported a 51% incidence of 30-day post-operative pulmonary complications, which included respiratory failure and post-operative pneumonia (PNA) [13] . This was consistent with an Italian study around this same time demonstrating a 15% incidence of 30-day acute respiratory failure [14] as well as a concurrent US study in hip surgery patients that reported a 14% incidence of post-operative mechanical ventilation [15] . A recently published study in non-surge conditions demonstrated an approximately 3 times increased risk of post-operative pulmonary complications in patients with pre-operative SARS-CoV-2 infection as far as 6 weeks pre-operatively [16] .

While these and other studies have contributed to a nearly universal cautionary approach to surgery in these patients, including a recommendation by the American Society of Anesthesiology and the Anesthesia Patient Safety Foundation to delay elective surgery for 4 weeks regardless of symptoms [17, 18] , there remain gaps in our understanding of this important problem. For example, most existing studies did not exclude patients with pre-operative respiratory failure or adjust for those with pre-operative symptomatic PNA. In one key study [13] , infection was considered present if viral RNA was detected up to 30-days after surgery.

Because this may include iatrogenic post-operative exposure, this complicates the applicability of this study's findings for pre-operative screening and risk stratification. Many studies also lacked a time-matched comparator group, which is key for interpreting observations during a pandemic when standard healthcare practices are necessarily modified. Additionally, some studies were limited to patients with SARS-CoV-2 detection within 1 week of surgery, which is not consistent with current 30-day pre-operative screening recommendations [18] . Finally, only one study differentiated between symptomatic and asymptomatic infection [16] .

The primary outcome was PORF, which was defined a priori as a composite of inability to extubate for ≥24 hours after surgical conclusion or unplanned re-intubation, high-flow nasal canula (HFNC), or non-invasive ventilation (NIV) within 5 days post-operatively. This definition and timeframe are consistent with recent studies of PORF as well as the timing of peak hypoxemia post-operatively [19] [20] [21] [22] [23] . Secondary outcomes included: 30-day post-operative mortality; new onset, intensivist-adjudicated PNA diagnosed by respiratory symptoms, imaging findings, and/or signs of systemic inflammation; acute kidney injury (AKI) as defined by a postoperative increase in serum creatine of ≥0.3 mg/dl; deep vein thrombosis (DVT) or pulmonary embolus (PE) detected by ultrasound or CT imaging; post-operative hospital and intensive care unit (ICU) length of stay (LOS); and 30-day re-operation need.

The exposure of interest was a positive SARS-CoV-2 nasal swab PCR test result within 4 weeks before or 5 days after surgery. The 5-day post-operative period was chosen to reflect the mean incubation period of SARS-CoV-2 infection and the assumption that a positive PCR test within this period likely reflected pre-operative viral exposure [24] . These patients were labeled as SARS-CoV-2 infected. We also noted any signs or symptoms of COVID-19 including intensivist-adjudicated respiratory or flu-like illness or consistent imaging findings. A large number of well-established pre-and intra-operative risk factors for PORF and COVID-19 were measured for each patient. Pre-operative variables included: age; sex; SARS-CoV-2 PCR results; chronic obstructive or respiratory lung disease, history of cancer (CA), dementia, and smoking status. To simplify multivariable analysis, most of these comorbidities were aggregated into the Charlson Comorbidity Index (CCI). Pre-operative physiologic parameters included routine vital signs, supplemental oxygen utilization, and 30-day pre-operative PNA adjudicated by an intensivist. Other peri-operative parameters included: ASA Physical Status (ASA-PS) classification; surgery type; 48-hour perioperative blood transfusion (i.e., any exogenous blood 24-hours before, during, or after surgery); and surgical risk and mortality prediction as estimated by the Surgical Mortality Probability Model (S-MPM) index. This latter index is composed of a patient's ASA-PS category, surgical emergency classification as defined by the attending anesthesiologist, and risk grade of surgery [25, 26] . Like CCI, S-MPM was used to consolidate variables and reduce collinearity in multivariable analysis.

Data were obtained with manual chart review combined with automated electronic health record extraction for surgical details and blood transfusion information. All statistical analyses were performed on Stata version SE 16.1 (StataCorp; College Station, TX, USA). Alpha was set at 0.05 for bivariate association testing. Continuous variables were tested for normality with histograms and normally distributed data were evaluated for their associations with either SARS-CoV-2 infection or PORF using two-tailed unpaired Student's T-tests and reported as mean (SD). Non-normal data were compared with Mann-Whitney rank-sum tests and reported as median (IQR 25-75%). Categorical data were compared using Chi-square and Fisher exact tests, J o u r n a l P r e -p r o o f where appropriate, and reported as proportions and odds ratios with 95% confidence intervals.

The Breslow-Day test was used to compare odds ratios between stratified cohort subgroups and evaluate for confounding versus effect modification. To adjust for independent predictors, confounders, and mediators of PORF, two separate multivariable logistic regression models were week pre-or 5 day post-operative SARS-CoV-2 positive nasopharyngeal PCR tests and these patients are hereon classified as SARS-CoV-2 infected.

As summarized in Table 1 Importantly, infected patients with suspicious x-ray findings but no symptoms whatsoever were labeled as asymptomatic given the possibility of false positive, non-specific findings.

Patients with SARS-CoV-2 infection also tended to have pre-operative vital signs consistent with sepsis ( Table 1) . Specifically, infected patients had slightly higher mean HR (89 vs. 82 bpm; P=0.001) and RR (18.8 vs. 18.2 breaths per minute; P=0.01) compared to uninfected patients. They also had a greater likelihood of requiring supplemental oxygen pre-operatively (20% vs. 10%; P=0.005). Specifically, nasal canula oxygen use was more frequent in infected patients (17% vs. 8%) while need for brief IMV, NIV, or HFNC for <24-hours before surgery was similar in both groups (3% vs. 2%). Consistent with their nearly 40% symptomatic presentation, SARS-CoV-2 infected patients were more likely to have pre-operative PNA (28% vs. 3%; P<0.001). Neither fever, MAP, nor individual systolic or diastolic blood pressures (data not shown) had any associations with viral infection.

Regarding surgical and anesthetic details, patients with SARS-CoV-2 infection tended to have higher risk indices ( Table 1) . For example, compared to uninfected patients, viral infection was associated with higher ASA-PS scores (20% vs. 34% with ASA 1-2, 61% vs. 50% ASA 3, and 20% vs. 16% ASA 4-5; P=0.02) as well as higher median S-MPM scores (5 vs. 4; P=0.02).

Regarding these greater S-MPM scores, they appeared to be driven primarily by higher ASA-PS scores as there were no associations between SARS-CoV-2 infection and emergency surgery classification (26% in infected vs. 20% in uninfected individuals) or the proportions of low-, intermediate-, and high-risk procedures according to S-MPM categorization (P=0.28). Use of general anesthesia as opposed to non-general anesthesia was slightly less frequent in SARS-CoV-2 infected patients (76% vs. 84%; P=0.04). There were no significant differences between J o u r n a l P r e -p r o o f groups with respect to the proportions of cardiothoracic or upper abdominal, lower abdominal or pelvic or cranial, or peripheral surgery. While surgery duration was similar between groups, use of exogenous blood products within 24-hours before or after surgery was more common in SARS-CoV-2 infected patients (26% vs. 16%; P=0.007).

As detailed in Table 2 , the incidence of PORF in this cohort was 59 out of 778 patients or 8%. Those who experienced PORF were older (median age 60-vs. 57-years; P=0.003) and had more comorbidities (median CCI 4 vs. 3; P<0.0001). Neither race, sex, nor chronic lung disease, obesity, nor smoking were associated with post-surgical respiratory failure. With respect to pre-operative clinical parameters, patients who experienced PORF had higher HR (median 86 vs. 80 bpm; P=0.001) and RR (median 18 in both groups but higher 75 th percentile in SARS-CoV-2 patients; P=0.02). Moreover, pre-operative oxygen saturation was lower (median SpO2 97% vs. 99%; P<0.0001) and supplemental oxygen need pre-operatively was greater in those who developed PORF compared to patients who did not (46% vs. 8%; P<0.001). Pre-operative PNA was also more common in those who went on to develop PORF (24% vs. 5%; P<0.001).

Patients with SARS-CoV-2 infection had a greater incidence of PORF than did With respect to surgical and anesthetic factors, PORF was more common in those with higher ASA-PS classification (ASA 4-5 in 59% of patients who developed PORF vs. 13% in patients who did not experience PORF; P <0.001). Emergency surgery was likewise associated with PORF (P <0.001) as was surgery type categorized by respiratory failure risk (P=0.0001) and To adjust for important confounders, mediators, and independent risk factors for PORF, for example pre-operative PNA, and better estimate the association between viral infection and respiratory failure, we generated two different logistic regression models ( Table 3) Table   4 ). Examining the individual subcomponents of the primary outcome revealed that SARS-CoV-2 infection was associated with unplanned reintubation within 5 days post-operatively (5% incidence in infected individuals vs. 1% in uninfected patients; P=0.03) as well as inability to extubate intra-operatively (11% vs. 4%; P=0.006). We also noted a greater incidence of new post-operative PNA in patients with SARS-CoV-2 infection, although this association was not statistically significant (11% vs. 5%; P=0.06). In unadjusted analyses, 30-day post-operative mortality occurred in 10% of SARS-CoV-2 patients compared to 3% of uninfected individuals (P<0.001). The median time from surgery to death was shorter in infected patients (7 vs. 14.5 days) and the incidence of PORF preceding death was greater in infected patients (67% vs. 56%), although these differences were not statistically significant. Post-operative hospital LOS until discharge alive or in-hospital death was longer in infected patients (median 6 vs. 3 days;

P=0.0001). Regarding 30-day mortality, we performed multivariable logistic regression and, after adjusting for CCI, pre-operative HR, and pre-operative S-MPM risk index, SARS-CoV-2 infection remained significantly associated with mortality (OR 3.5, 95% CI 1.4-9.1) as detailed in Table 5 .

J o u r n a l P r e -p r o o f

As hypothesized and supporting existing evidence, pre-operative SARS-CoV-2 infection as diagnosed with positive nasal PCR detection within 4 weeks before or 5 days after surgery was associated with a nearly 3 times increased adjusted odds of post-operative respiratory failure (PORF) relative to time-matched, uninfected comparator patients. Interestingly, this increased risk was present even after adjusting for probable mediators of this association, namely preoperative hypoxemia, supplemental oxygen need, and pre-operative pneumonia, suggesting an important causal mechanism beyond clinically evident pre-operative pulmonary dysfunction.

This association with respiratory failure may have been driven by the roughly 40% incidence of symptomatic COVID-19 as only symptomatic infection was significantly associated with PORF in unadjusted, exploratory analyses. Because nearly half of the cases of SARS-CoV-2 infection are asymptomatic [13, 14, 27] and surgical guidelines currently recommend a 30-day postponement of surgery irrespective of symptoms [18] , we feel this latter finding is particularly intriguing and hypothesis generating. It may be that if a patient is asymptomatic and has the same comorbidity and surgical characteristics as our study cohort, she or he may have no greater risk for post-operative respiratory failure compared to a patient who is not infected. Likewise, unadjusted analysis suggests the greatest risk with more acute 1-2 week pre-operative infection as opposed to less acute 3-4 week pre-operative infection. With regard to other surgical outcomes, SARS-CoV-2 infection was associated with a 3.5-fold adjusted increased 30-day postoperative mortality.

Although the incidence of PORF in SARS-CoV-2 infected patients in our cohort was on the lower end of the 14-51% range reported in previous studies during surge conditions [12] [13] [14] [15] , J o u r n a l P r e -p r o o f it is challenging to make comparisons due to different definitions and recruitment criteria. The substantially higher 51% incidence reported by the COVIDSurg Collaborative study may have been due to their screening of patients for infection only 7 days before and up to 30 days after surgery, which may have biased their cohort towards more acutely ill patients who may have had less time to heal before undergoing surgery. Additionally, the COVIDSurg Collaborative group screened for respiratory failure out to 30-days post-operatively compared to 5-days in this study, they did not exclude patients with pre-operative respiratory failure, and they included perioperative PNA as part of the composite post-operative pulmonary complication outcome.

Because nearly one-quarter of patients had PNA going into surgery, adding this to the composite outcome could inflate its incidence possibly up to the 51% incidence reported by the COVIDSurg Collaborative. Supporting this, Doglietto et al. reported a 14% incidence of PORF in their COVID-19 cohort and a substantially higher, 59% incidence when factoring in perioperative PNA [14] . Regarding this latter study, although the incidence of PORF in the present study was similar, Doglietto et al. reported a substantially higher 13 times increased odds of PORF. However, their comparator group was a historical matched cohort that had surgery performed under normal, pre-pandemic circumstances. Our use of a time-matched, uninfected comparator group therefore highlights the unique value of our study for characterization of PORF in SARS-CoV-2 infected patients.

Our data hint at an important synergy between COVID-19-and surgery-related immune dysfunction that may contribute to multiorgan injury including respiratory failure. It is well patients who experience severe disease [28, 29] . Not only did we observe a higher incidence of PORF in SARS-CoV-2 infected patients compared to non-infected controls, we identified a 4-6 times greater adjusted odds of PORF in patients who received blood component either 24-hours before or after surgery. Pre-pandemic studies have highlighted an increased incidence of both post-operative infection and respiratory complications in patients receiving transfusions [30] .

Moreover, inflammation itself is a well-established contributor to multiorgan dysfunction including acute kidney injury [31] and SARS-CoV-2 infection is associated with a proinflammatory state [32] . This complex inflammatory injury mechanism may account for our observation of a persistent association between SARS-CoV-2 infection and PORF despite adjusting for clear clinical markers of pre-operative pulmonary dysfunction including hypoxemia, pneumonia, and supplemental oxygen need.

There are several limitations to our study. First, this is a single-center retrospective study in a predominantly non-Caucasian cohort. Nevertheless, the comorbidity and outcome patterns are similar to those reported in previous studies with different demographics. Specifically, most patients with SARS-CoV-2 infection were elderly and had a high incidence of cardiovascular comorbidities [8, 9, 13, [33] [34] [35] . Likewise, infected patients were overall less healthy than uninfected individuals as indicated by their higher CCI, ASA-PS, and S-MPM scores. Moreover, this unique cohort is a valuable addition to the less diverse cohorts used in other studies, particularly as COVID-19 continues to ravage large parts of the developing world. Second, there is limited sample size and we must interpret with caution our intriguing observaitons of significantly increased odds of PORF with acute 1-2 week versus less acute 3-4 week preoperative infection as well as increased PORF with symptomatic versus asymptomatic disease .

However, this is the only study we are aware of that focuses on severe post-operative respiratory failure in a relatively unhealthy population needing urgent surgery, for which the risk of PORF is high and options for surgical delay are limited. Third, this study describes findings from the first COVID-19 surge in New York City when elective surgery was suspended and patients may have had delayed hospital presentation for fear of iatrogenic infection, consequently confounding associations between infection and post-operative complications relative to subsequent surges or in the periods in-between, during which mortality was generally lower [36] . We chose this unique time period because it was not yet universal to postpone surgery for 30-days after infection, there was a high prevalence of infection, and all findings in SARS-CoV-2 infected patients could be compared against non-infected patients as well as adjusted for emergency surgerical status and surgical risk, thereby ameliorating some of the latent confounding caused by epidemic-restrictive surgical practices. This latter aspect of our work is a key strength compared to other studies performed during this time evaluating risk relative to historical, uninfected controls. Moreover, the proportion of emergency surgeries was in fact lower in our cohort than in other studies [13, 14] . Nevertheless, it is difficult to apply these findings to patients with COVID-19 needing elective surgery or minor surgery with general anesthesia.

However, a recent study did not demonstrate any reduced risk of post-operative pulmonary complications in infected individuals having elective or minor surgery [16] . Fourth, although we were interested in pre-operative SARS-CoV-2 infection as a risk factor for PORF, 15% of patients defined as SARS-CoV-2 infected were in fact diagnosed within 5 days post-operatively.

This post-operative inclusion was permitted because SARS-CoV-2 pre-operative screening was not universal during this time, especially early in the surge, and it was necessary to extend screening for several days post-operatively to capture all infected patients. Moreover, as J o u r n a l P r e -p r o o f previously explained, given a median incubation time of 5-6 days, we felt that a positive nasopharyngeal screen within 5 days after surgery likely reflected pre-operative infection with subclinical disease on the day of surgery [24] . Lastly, we are assuming that nasopharyngeal detection of viral RNA reflects active SARS-CoV-2 infection. There is substantial evidence of false negative and positive tests [37] but this uncertainty is inherent in most COVID-19 studies.

There are several future directions for this work. As part of an effort to validate our findings in a later cohort that includes purely elective surgery, it will be important to further explore the association between PORF and symptomatic versus asymptomatic COVID-19 as well as acute versus less acute infection. It may also be interesting to compare incidence of respiratory failure in time-matched medical and surgical patients to explore further the role of various surgical and anesthetic factors in exacerbating infection, for example general compared to neuraxial or regional anesthesia. Finally, it will be important to characterize how long after initial infection this increased risk of post-operative respiratory failure persists to better establish the perioperative impact of so-called "Long Covid Syndrome" [7, 38] .

In conclusion, SARS-CoV-2 infection was found to be associated with increased odds of post-surgical respiratory failure after adjustment for confounders, mediators, and independent predictors of respiratory failure. This supports current surgical guidelines in the USA that recommend delaying non-urgent surgery for ≥4 weeks [18] and it suggests an important synergistic inflammatory mechanism driving PORF that may be modifiable with pharmacotherapy or alternative anesthetic or surgical techniques. Importantly, our observation of no association between asymptomatic infection and PORF in this non-elective surgery patient cohort highlights the continued uncertainty of this recommendation to delay surgery for asymptomatic patients needing higher risk, urgent or semi-urgent surgery that cannot be delayed J o u r n a l P r e -p r o o f for >4-6 weeks (e.g., oncologic surgery). If this latter finding is validated in future work, this may suggest greater flexibility and personalization by the peri-operative team is warranted.

Whether or not the COVID-19 pandemic subsides in the near future, this work adds to our knowledge of post-operative respiratory failure and may inform risk evaluation for future respiratory viral epidemics.

The J o u r n a l P r e -p r o o f J o u r n a l P r e -p r o o f 

Postoperative pulmonary complications. British journal of anaesthesia

A systematic review and consensus definitions for standardised end-points in perioperative medicine: pulmonary complications

Prediction of postoperative pulmonary complications in a population-based surgical cohort

Prospective external validation of a predictive score for postoperative pulmonary complications

Immune function after major surgical interventions: the effect of postoperative pain treatment

Cell response to surgery

Characteristics of and Important Lessons From the Coronavirus Disease 2019 (COVID-19) Outbreak in China: Summary of a Report of 72314 Cases From the Chinese Center for Disease Control and Prevention

Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. The Lancet Respiratory medicine

Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area

WHO. WHO Coronavirus Disease (COVID-19) Dashboard. Available at

Critical Care Surge During the COVID-19 Pandemic: Implementation and Feedback From Frontline Providers

Clinical characteristics and outcomes of patients undergoing surgeries during the incubation period of COVID-19 infection

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Factors Associated With Surgical Mortality and Complications Among Patients With and

COVID-19) in Italy

Increased Mortality and Major Complications in Hip Fracture Care During the COVID-19 Pandemic: A New York City Perspective

Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study

Joint Statement: Roadmap for Maintaining Essential Surgery during COVID-19

Accessed date

American Society of Anesthesiologists and Anesthesia Patient Safety Foundation Joint Statement on Elective Surgery and Anesthesia for Patients

Accessed date

Development and validation of a score to predict postoperative respiratory failure in a multicentre European cohort: A prospective, observational study

The development and validation of the Score for the Prediction of Postoperative Respiratory Complications J o u r n a l P r e -p r o o f (SPORC-2) to predict the requirement for early postoperative tracheal re-intubation: a hospital registry study

The LAS VEGAS risk score for prediction of postoperative pulmonary complications: An observational study

Postoperative Pulmonary Complications, Early Mortality, and Hospital Stay Following Noncardiothoracic Surgery: A Multicenter Study by the Perioperative Research Network Investigators

Time course of postoperative hypoxaemia. The European journal of surgery = Acta chirurgica

Incubation Period of Severe Acute Respiratory Syndrome Novel Coronavirus 2 that Causes Coronavirus Disease 2019: A Systematic Review and Meta-Analysis. Current therapeutic research, clinical and experimental

External Validation Of The Surgical Mortality Probability Model (S-MPM) In Patients Undergoing Non-Cardiac Surgery

The Surgical Mortality Probability Model: derivation and validation of a simple risk prediction rule for noncardiac surgery

Suppression of a SARS-CoV-2 outbreak in the Italian municipality of Vo'

Confronting the controversy: interleukin-6 and the COVID-19 cytokine storm syndrome. The European respiratory journal

Perioperative cytokine profile during lung surgery predicts patients at risk for postoperative complications-A prospective, clinical study

The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study

Inflammation in AKI: Current Understanding, Key Questions, and Knowledge Gaps

COVID-19 pathophysiology: A review

Clinical Characteristics of Covid-19 in New York City

Factors Associated With Death in Critically Ill Patients With Coronavirus Disease 2019 in the US

Epidemiology, clinical course, and outcomes of critically ill adults with COVID-19 in New York City: a prospective cohort study

Variation in US Hospital Mortality Rates for Patients Admitted With COVID-19 During the First 6 Months of the Pandemic

SARS CoV-2 Detection From Upper and Lower Respiratory Tract Specimens

This author helped with all aspects of this study including study conceptualization, data curation, validation, and analysis as well as supervision of the research team and preparation of this manuscript

This author helped with data collection and manuscript preparation and editing

This author helped with data collection and manuscript editing

Linzer: This author helped with data collection and manuscript editing

Labins: This author helped with data collection and manuscript editing

This author helped with data collection and manuscript editing

This author helped with data collection and manuscript editing

Gong: This author helped with study conceptualization, analysis of results, and manuscript review